Smith & Nephew SNATS Quick Ratio 2010-2024 | SNN
Smith & Nephew SNATS Quick Ratio Historical Data | |||
---|---|---|---|
Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
2024-12-31 | $2.03B | $1.53B | 1.33 |
2024-06-30 | $1.97B | $1.78B | 1.11 |
2023-12-31 | $1.64B | $2.27B | 0.72 |
2023-06-30 | $1.47B | $1.77B | 0.83 |
2022-12-31 | $1.65B | $1.72B | 0.96 |
2022-06-30 | $1.77B | $2.12B | 0.84 |
2021-12-31 | $2.58B | $2.13B | 1.21 |
2021-06-30 | $2.69B | $2.12B | 1.27 |
2020-12-31 | $2.97B | $1.69B | 1.76 |
2020-06-30 | $1.58B | $1.52B | 1.04 |
2019-12-31 | $1.61B | $1.56B | 1.03 |
2019-06-30 | $1.42B | $1.47B | 0.96 |
2018-12-31 | $1.68B | $1.47B | 1.15 |
2018-06-30 | $1.30B | $1.25B | 1.05 |
2017-12-31 | $1.43B | $1.35B | 1.06 |
2017-06-30 | $1.28B | $1.19B | 1.08 |
2016-12-31 | $1.29B | $1.35B | 0.95 |
2015-12-31 | $1.26B | $1.34B | 0.94 |
2015-06-30 | $1.25B | $1.23B | 1.02 |
2014-12-31 | $1.26B | $1.16B | 1.08 |
2014-09-30 | $1.32B | $1.23B | 1.08 |
2014-06-30 | $1.35B | $1.15B | 1.17 |
2014-03-31 | $1.32B | $1.06B | 1.24 |
2013-12-31 | $1.25B | $1.07B | 1.17 |
2013-09-30 | $1.19B | $1.03B | 1.16 |
2013-06-30 | $1.15B | $0.89B | 1.29 |
2013-03-31 | $1.16B | $0.92B | 1.26 |
2012-12-31 | $1.24B | $0.93B | 1.34 |
2012-09-30 | $1.40B | $0.91B | 1.54 |
2012-06-30 | $1.22B | $0.80B | 1.53 |
2012-03-31 | $1.43B | $1.03B | 1.40 |
2011-12-31 | $1.35B | $1.14B | 1.18 |
2011-09-30 | $1.32B | $1.29B | 1.02 |
2011-06-30 | $1.30B | $1.35B | 0.96 |
2011-03-31 | $1.27B | $0.88B | 1.44 |
2010-12-31 | $1.23B | $0.91B | 1.35 |
2010-09-30 | $1.40B | $0.86B | 1.62 |
2010-06-30 | $1.24B | $0.78B | 1.59 |
2010-03-31 | $1.18B | $0.88B | 1.34 |
2009-12-31 | $1.15B | $0.86B | 1.34 |
2009-09-30 | $1.16B | $0.91B | 1.28 |
2009-06-30 | $1.12B | $0.88B | 1.27 |
2009-03-31 | $1.09B | $1.00B | 1.09 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $13.165B | $5.810B |
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $233.364B | 28.06 |
Stryker (SYK) | United States | $146.969B | 30.73 |
Boston Scientific (BSX) | United States | $146.968B | 36.79 |
EssilorLuxottica (ESLOY) | France | $131.277B | 0.00 |
Medtronic (MDT) | Ireland | $112.813B | 15.99 |
Lonza Group Ag (LZAGY) | Switzerland | $50.710B | 0.00 |
Haleon (HLN) | United Kingdom | $49.016B | 27.92 |
ResMed (RMD) | United States | $37.047B | 27.83 |
Agilent Technologies (A) | United States | $34.235B | 22.32 |
GE HealthCare Technologies (GEHC) | United States | $33.847B | 16.07 |
Terumo (TRUMY) | Japan | $26.946B | 35.00 |
Koninklijke Philips (PHG) | Netherlands | $22.399B | 16.10 |
Insulet (PODD) | United States | $21.023B | 82.52 |
Zimmer Biomet Holdings (ZBH) | United States | $18.780B | 12.06 |
Baxter (BAX) | United States | $16.278B | 12.15 |
Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
Demant (WILYY) | Denmark | $8.854B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.273B | 21.83 |
Lantheus Holdings (LNTH) | United States | $5.564B | 14.03 |
Prestige Consumer Healthcare (PBH) | United States | $4.281B | 19.13 |
Perrigo (PRGO) | Ireland | $3.794B | 9.62 |
Haemonetics (HAE) | United States | $3.466B | 15.79 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
ICU Medical (ICUI) | United States | $3.367B | 24.83 |
Envista Holdings (NVST) | United States | $3.244B | 26.96 |
GN Store Nord (GNNDY) | Denmark | $2.180B | 18.06 |
QuidelOrtho (QDEL) | United States | $2.091B | 14.38 |
LeMaitre Vascular (LMAT) | United States | $1.890B | 42.24 |
AtriCure (ATRC) | United States | $1.653B | 0.00 |
Acuren (TIC) | United States | $1.314B | 0.00 |
Neogen (NEOG) | United States | $1.268B | 16.22 |
AdaptHealth (AHCO) | United States | $1.190B | 12.08 |
BioLife Solutions (BLFS) | United States | $1.136B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $1.063B | 23.91 |
Kestra Medical Technologies (KMTS) | United States | $1.053B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.987B | 12.61 |
InMode (INMD) | Israel | $0.920B | 9.27 |
CeriBell (CBLL) | United States | $0.640B | 0.00 |
Evolus (EOLS) | United States | $0.636B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.634B | 0.00 |
Owens & Minor (OMI) | United States | $0.629B | 5.22 |
Curaleaf Holdings (CURLF) | Canada | $0.565B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.550B | 0.00 |
Valneva SE (VALN) | France | $0.535B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.422B | 0.00 |
Surmodics (SRDX) | United States | $0.418B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.367B | 13.50 |
SNDL (SNDL) | Canada | $0.347B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.334B | 59.50 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.283B | 0.00 |
Canopy Growth (CGC) | Canada | $0.276B | 0.00 |
Cerus (CERS) | United States | $0.275B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.273B | 23.00 |
ZimVie (ZIMV) | United States | $0.266B | 12.09 |
Sanara MedTech (SMTI) | United States | $0.265B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.264B | 0.00 |
Quanterix (QTRX) | United States | $0.256B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.253B | 0.00 |
Omeros (OMER) | United States | $0.227B | 0.00 |
Biote (BTMD) | United States | $0.227B | 6.37 |
OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
Brainsway (BWAY) | Israel | $0.216B | 57.30 |
TriSalus Life Sciences (TLSI) | United States | $0.211B | 0.00 |
Organigram Global (OGI) | Canada | $0.191B | 0.00 |
High Tide (HITI) | Canada | $0.188B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.186B | 15.16 |
Verano Holdings (VRNOF) | United States | $0.180B | 0.00 |
Exagen (XGN) | United States | $0.157B | 0.00 |
Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
FitLife Brands (FTLF) | United States | $0.131B | 16.18 |
MacroGenics (MGNX) | United States | $0.112B | 0.00 |
Jin Medical (ZJYL) | China | $0.105B | 0.00 |
Veru (VERU) | United States | $0.098B | 0.00 |
Fonar (FONR) | United States | $0.092B | 11.88 |
Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.090B | 0.00 |
Agape ATP (ATPC) | $0.079B | 0.00 | |
TerrAscend (TSNDF) | Canada | $0.074B | 0.00 |
Apyx Medical (APYX) | United States | $0.069B | 0.00 |
InterCure (INCR) | Israel | $0.067B | 0.00 |
Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
Zynex (ZYXI) | United States | $0.066B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
ImmuCell (ICCC) | United States | $0.057B | 0.00 |
Modular Medical (MODD) | United States | $0.045B | 0.00 |
Nephros (NEPH) | United States | $0.041B | 55.43 |
United-Guardian (UG) | United States | $0.037B | 12.94 |
Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
Safety Shot (SHOT) | United States | $0.020B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.017B | 0.00 |
Flora Growth (FLGC) | United States | $0.016B | 0.00 |
INLIF (INLF) | $0.015B | 0.00 | |
Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
Senestech (SNES) | United States | $0.005B | 0.00 |
GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |